Kangmei Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of September 2025: 0.00%

Kangmei Pharmaceutical Co Ltd asset resilience ratio. Kangmei Pharmaceutical Co Ltd (600518) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 600518 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥91.40K

≈ $13.37K USD Cash + Short-term Investments

Total Assets

CN¥13.68 Billion

≈ $2.00 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Kangmei Pharmaceutical Co Ltd (2019–2024)

Asset resilience ratio of Kangmei Pharmaceutical Co Ltd from 2019 to 2024. This chart shows how Kangmei Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read 600518 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Kangmei Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Kangmei Pharmaceutical Co Ltd total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥91.40K	0.0%
Total Liquid Assets	CN¥91.40K	0.00%

Asset Resilience Insights

Limited Liquidity: Kangmei Pharmaceutical Co Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Kangmei Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Kangmei Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Galderma Group N SW:GALD	Drug Manufacturers - Specialty & Generic	3.56%
Enzymatica publ AB ST:ENZY	Drug Manufacturers - Specialty & Generic	22.17%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	9.04%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%

Kangmei Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2019–2024)

Kangmei Pharmaceutical Co Ltd asset resilience ratio by year from 2019 to 2024. The table below shows the annual Asset Resilience Ratio data for Kangmei Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.00%	CN¥80.96K ≈ $11.85K	CN¥13.80 Billion ≈ $2.02 Billion	+0.00pp
2023-12-31	0.00%	CN¥82.80K ≈ $12.12K	CN¥14.28 Billion ≈ $2.09 Billion	0.00pp
2022-12-31	0.00%	CN¥117.31K ≈ $17.17K	CN¥15.11 Billion ≈ $2.21 Billion	0.00pp
2021-12-31	0.00%	CN¥524.30K ≈ $76.72K	CN¥16.05 Billion ≈ $2.35 Billion	-0.01pp
2019-12-31	0.01%	CN¥5.88 Million ≈ $860.14K	CN¥64.59 Billion ≈ $9.45 Billion	--

pp = percentage points

About Kangmei Pharmaceutical Co Ltd

SHG:600518 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.59 Billion

CN¥17.70 Billion CNY

Market Cap Rank

#5141 Global

#812 in China

Share Price

CN¥1.28

Change (1 day)

+1.59%

52-Week Range

CN¥1.20 - CN¥2.13

All Time High

CN¥27.48